RP
Renosen Pharmaceuticals Private Limited IN IN · SEBI (PIT + SAST)
Browse the full record of transactions filed by Renosen Pharmaceuticals Private Limited. Insider active across 1 companies, notably Remus Pharmaceuticals Limited. Cumulatively, 73 filings have been published. The latest transaction was disclosed on 19 December 2025 (Purchase). Regulator: SEBI (PIT + SAST). The full history is accessible without signup.
Declarations 73 total
€3,543 500 shares @ €7.0866
Equity Shares
SEBI:8536e571a6c83a6c14cb994159fc90b28cebf536 · 19 Dec 2025
Ideal exit: 15 Sept 2026 (T+270) €1,399 200 shares @ €6.997
Equity Shares
SEBI:255ac3578df38b9d99108bb545ad7b1d3c3105d8 · 30 Sept 2025
Ideal exit: 27 Jun 2026 (T+270) €8,840 400 shares @ €22.1011
Equity Shares
SEBI:f695d17363a1c38e2e5b31c218c6a64cab453828 · 3 Feb 2025
Ideal exit: 31 Oct 2025 (T+270) €4,516 200 shares @ €22.5824
Equity Shares
SEBI:a0f7b85c06a2054c90323f30eb97f185a4e06962 · 3 Feb 2025
Ideal exit: 31 Oct 2025 (T+270) €2,556 100 shares @ €25.5576
Equity Shares
SEBI:3a2659fb138bc1e53d9fa32ccc6b3649120ab801 · 18 Sept 2024
Ideal exit: 15 Jun 2025 (T+270) €7,643 300 shares @ €25.4781
Equity Shares
SEBI:497032be8b5382fde6d8f7e61e504d6f6e9291a0 · 18 Sept 2024
Ideal exit: 15 Jun 2025 (T+270) €2,571 100 shares @ €25.708
Equity Shares
SEBI:12caf91c095ea315c4fd9e432f0c8cf8cf95caad · 18 Sept 2024
Ideal exit: 15 Jun 2025 (T+270) €2,545 100 shares @ €25.4502
Equity Shares
SEBI:6f162052571e4876a29e2cf72e55c43a3e7bd6fa · 18 Sept 2024
Ideal exit: 15 Jun 2025 (T+270) €7,751 300 shares @ €25.8369
Equity Shares
SEBI:9a0852ad46f853b3917002f2a1b332ee8b509bef · 18 Sept 2024
Ideal exit: 15 Jun 2025 (T+270) €49,352 2,000 shares @ €24.6762
Equity Shares
SEBI:51cb63b91d267ab74d4d053e4b8370023a67049e · 16 Aug 2024
Ideal exit: 13 May 2025 (T+270) €22,104 1,000 shares @ €22.1042
Equity Shares
SEBI:9b2ed14c3b8ea12df9bbe9aadd489562522a24ee · 5 Aug 2024
Ideal exit: 2 May 2025 (T+270) €33,265 1,500 shares @ €22.1765
Equity Shares
SEBI:c5f6cc05fedc4efdc9a3e0029a631a4f2f6aa69b · 5 Aug 2024
Ideal exit: 2 May 2025 (T+270) €22,131 1,000 shares @ €22.1312
Equity Shares
SEBI:71dcf15c795b1c88695bc266e2ca6628332a21ac · 5 Aug 2024
Ideal exit: 2 May 2025 (T+270) €2,273 100 shares @ €22.7342
Equity Shares
SEBI:d80b41a6edeb9433b8ba00b8c6afacb0557e3c52 · 5 Aug 2024
Ideal exit: 2 May 2025 (T+270) €2,264 100 shares @ €22.6419
Equity Shares
SEBI:600258396908e3559128ac5e02922e5b55c0d4b8 · 12 Jun 2024
Ideal exit: 9 Mar 2025 (T+270) €4,568 200 shares @ €22.841
Equity Shares
SEBI:d8fdd89336d03e9583399e9b30d0f48d89fe476d · 12 Jun 2024
Ideal exit: 9 Mar 2025 (T+270) €2,266 100 shares @ €22.6574
Equity Shares
SEBI:bf90b27808d550ac1c6695655f2c7bb3ce713e7b · 12 Jun 2024
Ideal exit: 9 Mar 2025 (T+270) €2,264 100 shares @ €22.6413
Equity Shares
SEBI:5c6373e3d0b58d3094f2e754c1a9ef0c4d0ba6f4 · 12 Jun 2024
Ideal exit: 9 Mar 2025 (T+270) €7,997 100 shares @ €79.9655
Equity Shares
SEBI:582ee520ff5aa7a22fad762dbd0597228184ed78 · 4 Jun 2024
Ideal exit: 1 Mar 2025 (T+270) €14,273 200 shares @ €71.3635
Equity Shares
SEBI:a72f85f704d1df22382275e540963d8c63f23737 · 4 Jun 2024
Ideal exit: 1 Mar 2025 (T+270) €7,795 100 shares @ €77.9498
Equity Shares
SEBI:15103e505ab29b6f802e88268a8d88e75d37eef2 · 4 Jun 2024
Ideal exit: 1 Mar 2025 (T+270) €1,916 25 shares @ €76.6334
Equity Shares
SEBI:e162ee35582ac442a28cba0ee74aee80541505c0 · 4 Jun 2024
Ideal exit: 1 Mar 2025 (T+270) €7,740 100 shares @ €77.3965
Equity Shares
SEBI:18046d4cc400c0ed744236fd09f3c7c9f6462c96 · 4 Jun 2024
Ideal exit: 1 Mar 2025 (T+270) €7,773 100 shares @ €77.7281
Equity Shares
SEBI:b974216bcea7553c6b8cb50c3498f14f414311f5 · 29 May 2024
Ideal exit: 23 Feb 2025 (T+270) €7,962 100 shares @ €79.6162
Equity Shares
SEBI:099f80710b26bf636f4448543015e6d64f00711f · 29 May 2024
Ideal exit: 23 Feb 2025 (T+270) 25 of 73 declarations
Load more (48 remaining)